Robert A. Jabulowsky

Author

University Medical Center of the Johannes Gutenberg University Mainz

Also Known As

R Jabulowsky, R. Jabulowsky, R.A. Jabulowsky, Robert A. Jabulowsky, Robert Alexander Jabulowsky, Robert Jabulowsky

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University Medical Center of the Johannes Gutenberg University Mainz Johannes Gutenberg University Mainz BioNTech (Germany)University Hospital Heidelberg Heidelberg University

About

Robert A. Jabulowsky is an author at University Medical Center of the Johannes Gutenberg University Mainz specializing in immunotherapy, medicine, and cancer vaccines.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	2.7K
2	Engineering	1	1	12
3	Health Sciences	1	1	21
4	Biomedical Engineering	1	1	12
5	Biomolecular Engineering	1	1	15

Robert A. Jabulowsky

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy Lena M. Kranz, Mustafa Diken, Heinrich Haas, Nature Cancer ImmunosurveillanceSystemic Rna DeliveryImmunologyAntiviral ResponseTherapeutic Vaccine	2016	1.7K
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma Uğur Şahin, Petra Oehm, Evelyna Derhovanessian, Nature Checkpoint-inhibitor-treated MelanomaMelanomaImmunologyTherapeutic VaccineCancer Vaccines	2020	961
Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity Axel V. Horn, Sabine Jung‐Klawitter, Ulrike Held, Nucleic Acids Research	2013	84
EGFR-Targeted Granzyme B Expressed in NK Cells Enhances Natural Cytotoxicity and Mediates Specific Killing of Tumor Cells Pranav Oberoi, Robert A. Jabulowsky, Hayat Bähr-Mahmud, PLoS ONE	2013	29
Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles Stefan Hutzler, Stephanie Erbar, Robert A. Jabulowsky, Scientific Reports	2017	26
Maltose-Binding Protein Enhances Secretion of Recombinant Human Granzyme B Accompanied by In Vivo Processing of a Precursor MBP Fusion Protein Benjamin Dälken, Robert A. Jabulowsky, Pranav Oberoi, PLoS ONE	2010	21
A shared tumor-antigen RNA-lipoplex vaccine with/without anti-PD1 in patients with checkpoint-inhibition experienced melanoma. Carmen Loquai, Jessica C. Hassel, Petra Oehm, Journal of Clinical Oncology ImmunologyImmunoeditingImmunotherapeuticsImmunotherapyCheckpoint-inhibition Experienced Melanoma	2020	21
Surface Charge-Modification Prevents Sequestration and Enhances Tumor-Cell Specificity of a Recombinant Granzyme B–TGFα Fusion Protein Robert A. Jabulowsky, Pranav Oberoi, Hayat Bähr-Mahmud, Bioconjugate Chemistry ImmunotherapeuticsCancer BiologyTumor BiologyTumor ImmunityCancer Cell Biology	2012	15
Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma Robert A. Jabulowsky, Carmen Loquai, Heidrun Mitzel-Rink, Cancer Research NanotherapeuticsEngineeringAbstract Ct156Tumor Antigen-encoding RnasImmunology	2018	12
A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy Ludwig Heesen, Robert A. Jabulowsky, Carmen Loquai, Annals of Oncology	2017	10

Page 1